100 related articles for article (PubMed ID: 302292)
1. Immunogenicity in weanling rabbits of a polyribophosphate complex from Haemophilus influenzae type b.
Anderson P; Smith DH
J Infect Dis; 1977 Aug; 136 Suppl():S63-70. PubMed ID: 302292
[TBL] [Abstract][Full Text] [Related]
2. A polysaccharide-protein complex from Haemophilus influenzae type b. I. Activity in weanling rabbits and human T lymphocytes.
Anderson P; Insel RA
J Infect Dis; 1981 Dec; 144(6):509-20. PubMed ID: 6977001
[TBL] [Abstract][Full Text] [Related]
3. Antibody of polyribophate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate.
Anderson P; Smith DH; Ingram DL; Wilkins J; Wehrle PF; Howie VM
J Infect Dis; 1977 Aug; 136 Suppl():S57-62. PubMed ID: 302291
[TBL] [Abstract][Full Text] [Related]
4. A polysaccharide-protein complex from Haemophilus influenzae type b. II. Human antibodies to its somatic components.
Insel RA; Anderson P; Loeb MR; Smith DH
J Infect Dis; 1981 Dec; 144(6):521-9. PubMed ID: 6977002
[TBL] [Abstract][Full Text] [Related]
5. A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults.
Anderson P; Insel RA; Smith DH; Cate TR; Couch RB; Glezen WP
J Infect Dis; 1981 Dec; 144(6):530-8. PubMed ID: 7035578
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.
Ambrosino D; Schreiber JR; Daum RS; Siber GR
Infect Immun; 1983 Feb; 39(2):709-14. PubMed ID: 6601060
[TBL] [Abstract][Full Text] [Related]
8. Fetal-neonatal passive immunization against Hemophilus influenzae, type b.
Amstey MS; Insel R; Munoz J; Pichichero M
Am J Obstet Gynecol; 1985 Nov; 153(6):607-11. PubMed ID: 3877464
[TBL] [Abstract][Full Text] [Related]
9. Management of recurrent invasive Haemophilus influenzae infection.
Fruchter L; Insel R
Am J Dis Child; 1981 Oct; 135(10):927-9. PubMed ID: 6975037
[TBL] [Abstract][Full Text] [Related]
10. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide.
Hunter KW; Fischer GW; Hemming VG; Wilson SR; Hartzman RJ; Woody JN
Lancet; 1982 Oct; 2(8302):798-9. PubMed ID: 6126667
[TBL] [Abstract][Full Text] [Related]
12. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
Donnelly JJ; Deck RR; Liu MA
J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
[TBL] [Abstract][Full Text] [Related]
14. Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults.
Insel RA; Kittelberger A; Anderson P
J Immunol; 1985 Oct; 135(4):2810-6. PubMed ID: 3897378
[TBL] [Abstract][Full Text] [Related]
15. Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B.
Lucas AH
J Clin Invest; 1988 Feb; 81(2):480-6. PubMed ID: 3257499
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B.
Johnston RB; Anderson P; Rosen FS; Smith DH
Clin Immunol Immunopathol; 1973 Jan; 1(2):234-40. PubMed ID: 4543490
[No Abstract] [Full Text] [Related]
17. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
18. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Wong VK; Quagliata R; Adler R; Kim KS
Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
[TBL] [Abstract][Full Text] [Related]
19. Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate.
Monji N; Stebbins MR; McCoy DW; Kuo JS
Infect Immun; 1986 Mar; 51(3):865-71. PubMed ID: 2868992
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.
Anderson P
Infect Immun; 1983 Jan; 39(1):233-8. PubMed ID: 6600444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
